References
- ColomboRNew procedures are bound to modify our attitude in facing urologic cancers in the near future: are we ready for a cost-effectiveness analysis?Eur Urol20075211417399890
- DaniltchenkoDIRiedlCRSachsMDLong-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized studyJ Urol2005174212933 discussion 213316280742
- FilbeckTPichlmeierUKnuechelRDo patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma?Urology2002601025812475663
- FilbeckTPichlmeierUKnuechelRReducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year studyUrologe A20034213667314569386
- JochamDWitjesFWagnerSImproved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter studyJ Urol2005174862616093971
- KiemeneyLAWitjesJAHeijbroekRPShould random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological GroupBr J Urol199473164718131019
- KriegmairMSteppHSteinbachPFluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasiasUrol Int19955519068588264
- KriegmairMZaakDRothenbergerKHTransurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopyJ Urol2002168475812131291
- LammDLCarcinoma in situUrol Clin North Am1992194995081636234
- LoidlWSchmidbauerJSusaniMFlexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?Eur Urol200547323615716195
- GrimbergenMCvan SwolCFJongesTGReduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapyEur Urol20034451612814675
- RaitanenMPAineRRintalaEFinnBladder GroupDifferences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysisEur Urol200241284912180229
- RiedlCRDaniltchenkoDKoenigFFluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancerJ Urol20011651121311257651
- SchmidbauerJWitjesFSchmellerNHexvix PCB301/01 Study GroupImproved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopyJ Urol2004171135814665861
- SylvesterRJvan der MeijdenAWitjesJAHigh-grade Ta urothelial carcinoma and carcinoma in situ of the bladderUrology200566Suppl 19010716399418
- WitjesJABladder carcinoma in situ in 2003: state of the artEur Urol200445142614733997
- WitjesJAMoonenPMvan der HeijdenAGComparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II studyEur Urol2005473192215716194
- ZaakDKarlAKnuchelRDiagnosis of urothelial carcinoma of the bladder using fluorescence endoscopyBJU Int2005962172216001963
- ZaakDKriegmairMSteppHEndoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopiesUrology200157690411306382
- ZaakDHungerhuberESchneedePRole of 5-aminolevulinic acid in the detection of urothelial premalignant lesionsCancer2002951234812216090